1. Home
  2. RBOT vs TELO Comparison

RBOT vs TELO Comparison

Compare RBOT & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBOT
  • TELO
  • Stock Information
  • Founded
  • RBOT 2014
  • TELO 2021
  • Country
  • RBOT United States
  • TELO United States
  • Employees
  • RBOT N/A
  • TELO N/A
  • Industry
  • RBOT Medical Specialities
  • TELO
  • Sector
  • RBOT Health Care
  • TELO
  • Exchange
  • RBOT Nasdaq
  • TELO NYSE
  • Market Cap
  • RBOT 46.7M
  • TELO 52.4M
  • IPO Year
  • RBOT N/A
  • TELO 2024
  • Fundamental
  • Price
  • RBOT $7.93
  • TELO $1.19
  • Analyst Decision
  • RBOT Hold
  • TELO
  • Analyst Count
  • RBOT 2
  • TELO 0
  • Target Price
  • RBOT $9.25
  • TELO N/A
  • AVG Volume (30 Days)
  • RBOT 10.7K
  • TELO 403.6K
  • Earning Date
  • RBOT 08-11-2025
  • TELO 08-12-2025
  • Dividend Yield
  • RBOT N/A
  • TELO N/A
  • EPS Growth
  • RBOT N/A
  • TELO N/A
  • EPS
  • RBOT N/A
  • TELO N/A
  • Revenue
  • RBOT N/A
  • TELO N/A
  • Revenue This Year
  • RBOT N/A
  • TELO N/A
  • Revenue Next Year
  • RBOT N/A
  • TELO N/A
  • P/E Ratio
  • RBOT N/A
  • TELO N/A
  • Revenue Growth
  • RBOT N/A
  • TELO N/A
  • 52 Week Low
  • RBOT $4.27
  • TELO $1.13
  • 52 Week High
  • RBOT $19.00
  • TELO $8.40
  • Technical
  • Relative Strength Index (RSI)
  • RBOT 50.26
  • TELO 25.13
  • Support Level
  • RBOT $7.21
  • TELO $1.13
  • Resistance Level
  • RBOT $8.09
  • TELO $1.81
  • Average True Range (ATR)
  • RBOT 0.45
  • TELO 0.13
  • MACD
  • RBOT -0.02
  • TELO -0.03
  • Stochastic Oscillator
  • RBOT 53.10
  • TELO 6.55

About RBOT Vicarious Surgical Inc.

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

Share on Social Networks: